🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Ajanta Pharma Limited AJANTPHARM NIFTY_MIDNSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://www.ajantapharma.com
Company Profile ↓
₹3,413.60
+33.21% 1Y
Mkt Cap₹42,648.02 Cr
P/E40.39
P/B9.44
Div. Yield1.67%
52W High₹3,422.70
52W Low₹2,361.91
Book Value₹362.35
EPS (TTM)₹84.51

Company Overview

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 23.3%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 29.4%.

Consistent Profit Growth

Net profit has compounded at 21.6% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 13.4% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 19.5%.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.06.

Recent Developments

  • Mar 2026 Revenue of ₹5,407.26 Cr (+17.9% YoY); net profit ₹1,056.00 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +17.9%, earnings +14.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 13.4%, profit CAGR 21.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:13.40%
1 Year:17.87%

Compounded Profit Growth

5 Years:21.55%
1 Year:14.73%

Stock Price Performance

1 Year:+33.21%
6 Months:+20.26%
3 Months:+20.72%
1 Month:+11.76%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 99% of range
₹2,361.91 ₹3,422.70
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)64.66 · Neutral
Price Performance
1M+11.76%
3M+20.72%
6M+20.26%
1Y+33.21%
Valuation vs Sector

P/E of 40.39 is above the sector median of 39.97 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 23.3%.
  • Healthy ROCE of 29.4%.
  • Compounding revenue at 13.4% over 5 years.
  • Profit CAGR of 21.6% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
40.39
Industry PE
39.97
Forward P/E
29.99
PEG Ratio
-
Book Value
₹362.35
Price to Book
9.44
P/S
7.84
EV/EBITDA
27.66
Dividend Yield
1.67%

Growth (CAGR)

Revenue 5Y
13.40%
Profit 5Y
21.55%
Revenue (YoY)
17.87%
Earnings (YoY)
14.73%

Profitability & Returns

ROCE
29.41%
ROE
23.33%
ROA
17.16%
Profit Margin
19.53%
Op Margin
24.53%
Gross Margin
76.93%
EPS (Latest Qtr)
₹21.34
EPS (TTM)
₹84.51

Balance Sheet & Liquidity

Debt/Equity
0.06
Quick Ratio
1.98
Current Ratio
2.64
Debt
₹260.17 Cr
Total Assets
₹6,154.84 Cr
Current Assets
₹3,735.43 Cr
Working Capital
₹2,319.68 Cr

Ownership

Promoter Holding
63.36%
Chg in Prom Hold
-0.04%
FII / Inst Holding
21.67%
Chg in FII Hold
0.05%

Financial Snapshot

Enterprise Value
₹42,648.02 Cr
Total Revenue (TTM)
₹5,407.26 Cr
EBITDA
₹1,566.90 Cr
Free Cash Flow
₹164.03 Cr
Operating Cash Flow
₹529.19 Cr
Shares Outstanding
₹12.49 Cr
Gross Margin
76.93%
Payout Ratio
33.13%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 AJANTPHARM Ajanta Pharma Limited NIFTY_MIDNSEPHARMA 3,413.60 40.39 ₹42,648.02 Cr 1.67% 29.41% 23.33% 13.40% 21.55%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 882.00 Cr1,021.00 Cr1,028.00 Cr1,105.00 Cr1,054.00 Cr1,145.00 Cr1,187.00 Cr1,146.13 Cr1,170.41 Cr1,302.65 Cr1,354.00 Cr1,374.84 Cr1,421.64 Cr
Cost of Revenue -------257.81 Cr283.42 Cr275.88 Cr-286.26 Cr304.81 Cr
Gross Profit -------888.32 Cr886.99 Cr1,026.77 Cr-1,088.58 Cr1,116.83 Cr
Operating Expenses 732.00 Cr750.00 Cr738.00 Cr791.00 Cr776.00 Cr815.00 Cr875.00 Cr301.14 Cr319.56 Cr344.19 Cr1,026.00 Cr374.03 Cr386.09 Cr
Operating Income 116.00 Cr238.00 Cr257.00 Cr280.00 Cr244.00 Cr296.00 Cr277.00 Cr587.18 Cr567.43 Cr682.58 Cr285.00 Cr714.55 Cr730.74 Cr
EBITDA 149.00 Cr271.00 Cr291.00 Cr314.00 Cr278.00 Cr330.00 Cr311.00 Cr351.27 Cr315.26 Cr377.68 Cr328.00 Cr407.21 Cr394.84 Cr
Interest Expense 1.00 Cr1.00 Cr2.00 Cr2.00 Cr2.00 Cr1.00 Cr6.00 Cr7.91 Cr6.07 Cr5.26 Cr3.00 Cr5.10 Cr2.36 Cr
Pretax Income 152.00 Cr269.00 Cr276.00 Cr291.00 Cr278.00 Cr322.00 Cr290.00 Cr307.39 Cr269.41 Cr331.13 Cr341.00 Cr358.60 Cr347.11 Cr
Tax Provision 30.40 Cr61.87 Cr80.04 Cr81.48 Cr75.06 Cr77.28 Cr72.50 Cr74.51 Cr44.15 Cr75.79 Cr81.84 Cr84.83 Cr80.41 Cr
Net Income 122.00 Cr208.00 Cr195.00 Cr210.00 Cr203.00 Cr246.00 Cr216.00 Cr232.88 Cr225.26 Cr255.34 Cr260.00 Cr273.77 Cr266.70 Cr
Diluted EPS 9.5416.2415.2416.3915.8219.6817.3318.5918.0020.4320.8321.9121.34

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 1,474.00 Cr1,749.00 Cr1,983.00 Cr2,126.00 Cr2,055.00 Cr2,588.00 Cr2,890.00 Cr-3,707.52 Cr4,161.59 Cr4,587.51 Cr5,407.26 Cr
Cost of Revenue --------1,116.73 Cr1,115.32 Cr1,127.15 Cr1,247.70 Cr
Gross Profit --------2,590.79 Cr3,046.27 Cr3,460.36 Cr4,159.56 Cr
Operating Expenses 968.00 Cr1,155.00 Cr1,292.00 Cr1,467.00 Cr1,489.00 Cr1,904.00 Cr1,889.00 Cr-1,911.03 Cr2,000.63 Cr2,331.90 Cr2,832.96 Cr
Operating Income 453.00 Cr550.00 Cr630.00 Cr598.00 Cr495.00 Cr587.00 Cr885.00 Cr-679.76 Cr1,045.64 Cr1,128.46 Cr1,326.60 Cr
EBITDA 505.00 Cr594.00 Cr691.00 Cr658.00 Cr567.00 Cr683.00 Cr1,001.00 Cr-881.89 Cr1,256.54 Cr1,354.00 Cr1,566.90 Cr
Interest Expense 6.00 Cr5.00 Cr1.00 Cr01.00 Cr12.00 Cr8.00 Cr-5.84 Cr7.21 Cr20.73 Cr16.11 Cr
Pretax Income 456.00 Cr559.00 Cr648.00 Cr623.00 Cr514.00 Cr664.00 Cr900.00 Cr-745.25 Cr1,113.93 Cr1,189.16 Cr1,377.65 Cr
Tax Provision 145.92 Cr145.34 Cr142.56 Cr155.75 Cr128.50 Cr199.20 Cr243.00 Cr-157.27 Cr297.76 Cr268.77 Cr321.65 Cr
Net Income 310.00 Cr416.00 Cr507.00 Cr469.00 Cr387.00 Cr468.00 Cr654.00 Cr-587.98 Cr816.17 Cr920.39 Cr1,056.00 Cr
Diluted EPS 23.4731.4938.4035.5029.5635.7350.38-45.8964.7773.5384.51

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 1,146.00 Cr1,479.00 Cr1,823.00 Cr2,426.00 Cr2,664.00 Cr3,293.00 Cr3,729.00 Cr-4,679.02 Cr4,638.39 Cr5,014.95 Cr6,154.84 Cr
Current Assets --------2,834.00 Cr2,730.92 Cr2,843.03 Cr3,735.43 Cr
Cash & Equivalents --------329.83 Cr129.49 Cr175.12 Cr103.26 Cr
Inventory --------815.63 Cr828.36 Cr903.85 Cr938.54 Cr
Receivables --------1,056.90 Cr1,246.84 Cr1,182.74 Cr1,853.88 Cr
Total Liabilities --------1,291.03 Cr1,071.02 Cr1,224.66 Cr1,627.75 Cr
Current Liabilities --------1,139.28 Cr895.25 Cr996.10 Cr1,415.75 Cr
Long Term Debt -------1.64 Cr1.25 Cr0--
Total Debt 72.00 Cr81.00 Cr1.00 Cr2.00 Cr36.00 Cr75.00 Cr31.00 Cr-35.63 Cr35.28 Cr47.42 Cr260.17 Cr
Total Equity 841.00 Cr1,191.00 Cr1,568.00 Cr2,042.00 Cr2,246.00 Cr2,599.00 Cr2,995.00 Cr-3,387.99 Cr3,567.37 Cr3,790.29 Cr4,527.09 Cr
Shares Outstanding --------12.67 Cr12.59 Cr12.49 Cr12.49 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 279.00 Cr326.00 Cr609.00 Cr281.00 Cr375.00 Cr457.00 Cr576.00 Cr-792.11 Cr785.07 Cr1,157.23 Cr529.19 Cr
Investing Cash Flow -158.00 Cr-209.00 Cr-383.00 Cr-256.00 Cr-223.00 Cr-224.00 Cr-282.00 Cr--559.60 Cr65.39 Cr-376.52 Cr-428.92 Cr
Financing Cash Flow -105.00 Cr-117.00 Cr-202.00 Cr-0-147.00 Cr-129.00 Cr-318.00 Cr--108.20 Cr-1,051.06 Cr-733.41 Cr-167.92 Cr
Capital Expenditure -103.00 Cr-297.00 Cr-296.00 Cr-262.00 Cr-343.00 Cr-229.00 Cr-159.00 Cr--174.49 Cr-152.41 Cr-317.92 Cr-365.16 Cr
Free Cash Flow 176.00 Cr29.00 Cr313.00 Cr19.00 Cr32.00 Cr228.00 Cr417.00 Cr-617.62 Cr632.66 Cr839.31 Cr164.03 Cr
Net Change in Cash 16.00 Cr-024.00 Cr25.00 Cr4.00 Cr104.00 Cr-24.00 Cr-124.31 Cr-200.60 Cr47.30 Cr-67.65 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------69.9%73.2%75.4%76.9%
Operating Margin % 30.7%31.4%31.8%28.1%24.1%22.7%30.6%-18.3%25.1%24.6%24.5%
Net Margin % 21.0%23.8%25.6%22.1%18.8%18.1%22.6%-15.9%19.6%20.1%19.5%
ROE % 36.9%34.9%32.3%23.0%17.2%18.0%21.8%-17.4%22.9%24.3%23.3%
ROCE % --------19.2%27.9%28.1%28.0%

Shareholding Pattern

Insiders
63.36%
Institutions
21.67%
Public Float
59.15%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AJANTPHARM

Google News Sat, 27 Jun 2026

AJANTPHARM Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE91S3Bpb1hmTkQxcEt3Nm1BWmliNnJxSUFZTHBVamlZVHJZazd5TnBQVkxJZm1vS1RqTGtUTzIyTVhiaWpBR2tBRXpiOXJWOGIxX1NITWJLQlFTSkhDekQ4OGhmNThEWGNGaWtHN0ZOSS1kYUlaamM5emlneVVUZw?oc=5" target="_blan…

Google News Wed, 13 May 2026

We Think That There Are Some Issues For Ajanta Pharma (NSE:AJANTPHARM) Beyond Its Promising Earnings - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxPSFNhVEduSklmSG5lcElyQ3IxMVphODdTMlpsVVpvdndwa3k4VEhjYUtVa1RqeUl0T0NWTXdnelVIVUYxQU9fVmtfMld0Q1lCUEVObFBhaFhxc0lBRzduYzNVX0dOb3Z5NjBvZV8zUWFCQ2pyTDk0NUFRRUFmbm5DTC1wYlVXOXdjaGNtM0…

Google News Mon, 05 Jan 2026

Are Robust Financials Driving The Recent Rally In Ajanta Pharma Limited's (NSE:AJANTPHARM) Stock? - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxNdlZoMjN6bWgtWGd5dGtQOVlkN1hhWmR6UGthVW1sdmhsNXBlWTJiQXVxaWpNUS1tVGtxRkt5OXg2bTVkNjBaNUtoZldSOXlEUndQUjY3OGV1Ylk4NHBYeWszMThwa251bFNnSUtsSkdBbmdrTnlDbWNPZ1ZaNmZYZFFkQ0NWSWdCa3lOWV…

Google News ue, 14 Apr 2026

Ajanta Pharma Ltd. Share Price Today - Ajanta Pharma Ltd. Stock Price Live NSE/BSE - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxOUlczX3JCOWF6T1dYS3RwcG1BVnNKRTNpbU5FM0RWeWdPbUliS1dmdzUycGZNU3Y5Y1hkTndkNDdveEY5Z3BBVTM2Ny1EdmJtcGxrWXFUX2ZyTDlKSkkzWjBtWm55RGdYSElERWs0VWRnWjFzQkR2MVpMTlk5WW1qRGx3?oc=5" target=…

Google News Sat, 05 Jul 2025

AJANTPHARM Stock Price and Chart — NSE:AJANTPHARM - TradingView

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9HVUZKSHNRbmo1UWdWeHFEdEhac2kzOGFsZVhiTF9nMHpsNVpiMHBXLVc0ZlVPMm94Zzk5b3M2dS13cnNBa1RYLW9yeWFndkxCLWxvZEVxLXIxQXVYQlJJdw?oc=5" target="_blank">AJANTPHARM Stock Price and Chart — NS…

Google News hu, 06 Nov 2025

Ajanta Pharma (NSE:AJANTPHARM) Has Announced A Dividend Of ₹28.00 - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxPMEx4V094ZGJFNXFWQ1FPYThENjZ5M0xFVWV2ZGplSGp0OWtkeEhSdENjaExEUnlMTW1aYm5MNzh0enhfdmVGaXl1N0doTWtCdWJ2TGhOcXJoVmVRSVlrM3lrdEVLSDdfQnRIUzRMNVk0SWdyXy15WGpzUU96NjBBNmYwNUlIUU9hZDYzZE…

AJANTPHARM — Frequently Asked Questions

What is the current share price of Ajanta Pharma Limited (AJANTPHARM)?

As of 2026-07-15 09:52 IST, Ajanta Pharma Limited (AJANTPHARM) trades at ₹3,413.60 on NSE. Its 52-week range is ₹2,361.91 to ₹3,422.70.

What is the market capitalisation of AJANTPHARM?

Ajanta Pharma Limited (AJANTPHARM) has a market capitalisation of ₹42,648.02 Cr on NSE.

What is the P/E ratio of AJANTPHARM?

AJANTPHARM trades at a trailing price-to-earnings (P/E) ratio of 40.39. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 9.44.

Does AJANTPHARM pay a dividend?

Ajanta Pharma Limited (AJANTPHARM) currently offers a dividend yield of 1.67%.

What is the return on equity (ROE) of AJANTPHARM?

AJANTPHARM has a return on equity (ROE) of 23.33%. Its return on capital employed (ROCE) is 29.41%.

Is AJANTPHARM a good stock to buy?

This page provides a data-driven analysis of Ajanta Pharma Limited (AJANTPHARM), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space